Viewing Study NCT01107951


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2025-12-25 @ 9:52 PM
Study NCT ID: NCT01107951
Status: COMPLETED
Last Update Posted: 2013-03-22
First Post: 2010-04-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP
Sponsor: Hospital Universitario Dr. Jose E. Gonzalez
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module